$HIMS (-26,15%) BREAKING: THE SEMAGLUTIDE DEFICIENCY HAS BEEN OFFICIALLY RESOLVED ACCORDING TO THE FDA
1: GLP-1 only accounts for 10% of revenue.
2: Can they still sell GLP-1, just with a different composition.
Plus, it now brings more stability to the core, I'm bullish!
